Published on: August 2 2022
Contributed by: Matthew T. Carpenter, Anna Dimitrijević and Alec G. Miller, Co-Editors, XBMA Review
Executive Summary/Highlights Global dealmaking was up in Q2 2022 as compared to Q1 2022, and year-to-date is on pace with pre-pandemic deal volume (although below last year’s record-breaking levels). Global M&A volume was US$1.14 trillion in Q2 2022, an 11% increase from Q1 2022, but a 26% decrease from Q2 2021. Several mega deals were … Continued
Published on: July 8 2022
Contributed by: Martin Lipton, Founding Partner, Wachtell, Lipton, Rosen & Katz (New York)
We recently wrote about the emergence of a new breed of business organizations — decentralized autonomous organizations (DAOs) — to contend that the governance design for these blockchain-based organizations should heed some of the hard-fought lessons that have helped to form the pillars of modern corporate governance. It is also important to confront certain features … Continued
Published on: April 29 2022
Contributed by: Matthew T. Carpenter, Anna Dimitrijević and Alec G. Miller, Co-Editors, XBMA Review
Executive Summary/Highlights After a record-breaking 2021 in which global M&A volume surged to a new peak, global dealmaking slowed in the first quarter of 2022. Global M&A volume was approximately US$1.0 trillion in Q1 2022, less than any of the prior six quarters. Despite a decline in M&A activity relative to the record-breaking volumes of … Continued
Published on: March 29 2022
Contributed by: Vincent Mercier, Partner, Davies Ward Phillips & Vineberg (Toronto)
The past year generated substantial interest in the operation of the Investment Canada Act (ICA), especially the national security review process, against the backdrop of changes in government policy that purport to articulate a more expansive view of Canada’s national security interests. We expect foreign investment review to remain an issue of public and political concern in … Continued
Published on: February 22 2022
Contributed by: Matthew T. Carpenter and Anna Dimitrijević, Co-Editors, XBMA Review
Executive Summary/Highlights Global M&A volume was more than US$5.8 trillion in 2021, the highest annual volume on record. Each of the four quarters of 2021 was one of the top six most active quarters by dollar volume since the beginning of 2010. In addition to a legion of private equity funded transactions, including such major … Continued
Published on: January 31 2022
Contributed by: Martin Lipton, Founding Partner, Wachtell, Lipton, Rosen & Katz (New York)
Introduction The Biden administration has just completed its first full year in office, and the talk has been tough. New leadership at DOJ, the SEC, the FTC, the CFTC, and other regulatory and law enforcement agencies have issued statements and policy revisions signaling their intention to train more focus on white-collar and regulatory enforcement. We … Continued
Published on: January 7 2022
Contributed by: Adam Li and Fang He, partners at JunHe and members of XBMA's Legal Roundtable. Mr. Li is a leading expert in international mergers and acquisitions, capital markets and international financial transactions involving Chinese companies. Ms. He has broad experience in M&A, outbound investment, foreign direct investment, and private equity. This article was authored by Wang Yi and Xiaojia Sun, partners at JunHe.
*Originally distributed on December 31, 2021 The second half of 2021 was an extraordinary time for Chinese companies seeking to list overseas, as well as for other relevant market participants. The Didi incident further deepened the anxiety and “mistrust” by US securities regulators on the risks associated with investing in China-based companies or that have … Continued
Published on: January 3 2022
Contributed by: Martin Lipton, Founding Partner, Wachtell, Lipton, Rosen & Katz (New York)
Since early 2020, a consortium of well-funded plaintiffs’ law firms have pursued an aggressive campaign of derivative litigation in the New York courts against major European companies, including Deutsche Bank, UBS, Volkswagen, Barclays, Novartis, and Bayer (represented by this Firm). While the lawsuits differed in detail, they shared a strategic purpose: to drag international companies … Continued
Published on: November 10 2021
Contributed by: Matthew T. Carpenter and Anna Dimitrijević, Co-Editors, XBMA Review
Executive Summary/Highlights The boom in global M&A activity reached new heights in the third quarter of 2021, resulting in a record volume of global M&A through the first three quarters. M&A activity has surged on the back of pent-up demand for deals following the Covid-19 shutdown in the early part of 2020 and the subsequent … Continued
Published on: July 22 2021
Contributed by: Matthew T. Carpenter and Caley M. Petrucci, Co-Editors, XBMA Review
Executive Summary/Highlights Global M&A activity reached historic levels in the first half of 2021, amounting to one of the highest first-half deal volumes on record. The surge in M&A activity following the early-pandemic shutdown has continued for the last 12 months, driven by a bull market, economic stimulus, corporate priorities to adapt to changes in … Continued